REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Talis Biomedical Corp. (TLIS) on Thursday reported a loss of $15 million in its second quarter.

The Redwood City, California-based company said it had a loss of $8.27 per share.

The infectious disease diagnostics company posted revenue of $581,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TLIS at https://www.zacks.com/ap/TLIS

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News